Daptomycin 71839-0108
Product NDC
71839-0108- Manufacturer
- Be Pharmaceuticals Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 20, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA213425
Need to source Daptomycin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Daptomycin | 350 mg/7mL |
Drug Class
Lipopeptide Antibacterial [EPC]Lipopeptide Antibacterial [EPC]Lipopeptides [CS]
Packaging Options(2)
1 VIAL in 1 CARTON (71839-108-01) / 7 mL in 1 VIAL
10 VIAL in 1 CARTON (71839-108-10) / 7 mL in 1 VIAL